Trial intelligence / Profile preview

Neurodevelopment after standard-dose sevoflurane versus low-dose sevoflurane with dexmedetomidine/remifentanil in young children

2024-512385-34-00Phase 3Completed

Sponsor
Istituto Giannina Gaslini
Start
Sep 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
3
01

Overview

Phase 3, randomised trial comparing Standard-dose sevoflurane with Low-dose sevoflurane + dexmedetomidine + remifentanil (2 arms). Primary endpoint: Full scale IQ score. Started Sep 2020; status: completed.

02

Drugs

sevofluranedexmedetomidineremifentanil

Beyond the preview

Go deeper on 2024-512385-34-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-512385-34-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call